Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
AK134499
| |
AK134499 |
11 days embryo head cDNA, RIKEN full-length enriched library, clone:6230419C23 product:unclassifiable, full insert sequence [AK134499] |
KLA | .97 |
1.04 |
.99 |
1.01 |
.93 |
1.08 |
1.21 |
| ATP | .97 |
1.02 |
.97 |
1.13 |
1.01 |
.98 |
1.06 |
| KLA/ATP | .95 |
.98 |
1.00 |
.95 |
1.00 |
.98 |
1.02 |
|
Acp1 | |
NM_001110239 |
acid phosphatase 1, soluble (Acp1), transcript variant 1, mRNA [NM_001110239] |
KLA | 1.15 |
1.18 |
1.12 |
1.18 |
1.14 |
1.10 |
1.18 |
| ATP | .94 |
1.01 |
1.12 |
1.23 |
.90 |
.68 |
.98 |
| KLA/ATP | 1.10 |
1.24 |
1.20 |
1.33 |
.94 |
.82 |
.99 |
|
Acp2 | |
AK170658 |
NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630113A07 product:acid phosphatase 2, lysosomal, full insert sequence [AK170658] |
KLA | 1.17 |
1.24 |
1.33 |
1.51 |
2.46 |
3.34 |
3.43 |
| ATP | .95 |
.99 |
.76 |
1.07 |
.73 |
.56 |
.97 |
| KLA/ATP | 1.23 |
1.23 |
.78 |
1.06 |
.72 |
.78 |
2.19 |
|
Acp2 | |
NM_007387 |
acid phosphatase 2, lysosomal (Acp2), mRNA [NM_007387] |
KLA | 1.52 |
1.61 |
1.73 |
1.82 |
2.82 |
4.19 |
5.68 |
| ATP | 1.12 |
1.21 |
.95 |
1.29 |
.87 |
.76 |
2.68 |
| KLA/ATP | 1.81 |
1.80 |
1.24 |
1.72 |
1.04 |
1.16 |
5.43 |
|
Acp5 | |
NM_007388 |
acid phosphatase 5, tartrate resistant (Acp5), transcript variant 3, mRNA [NM_007388] |
KLA | 3.62 |
3.55 |
3.27 |
3.26 |
3.31 |
3.93 |
5.79 |
| ATP | .96 |
1.00 |
1.29 |
1.96 |
2.30 |
3.05 |
3.81 |
| KLA/ATP | 3.61 |
3.85 |
4.05 |
5.38 |
4.56 |
5.15 |
6.77 |
|
Acp6 | |
NM_019800 |
acid phosphatase 6, lysophosphatidic (Acp6), mRNA [NM_019800] |
KLA | .56 |
.47 |
.41 |
.37 |
.24 |
.32 |
.79 |
| ATP | .88 |
.80 |
1.06 |
.84 |
.62 |
.51 |
.67 |
| KLA/ATP | .49 |
.44 |
.49 |
.36 |
.34 |
.37 |
.39 |
|
Acpp | |
NM_019807 |
acid phosphatase, prostate (Acpp), transcript variant 2, mRNA [NM_019807] |
KLA | 1.09 |
1.07 |
1.11 |
1.23 |
1.20 |
1.08 |
1.14 |
| ATP | 1.00 |
1.02 |
1.07 |
1.03 |
1.00 |
2.39 |
3.55 |
| KLA/ATP | 1.02 |
1.12 |
1.04 |
1.10 |
1.05 |
1.69 |
4.36 |
|
Acpp | |
NM_207668 |
acid phosphatase, prostate (Acpp), transcript variant 1, mRNA [NM_207668] |
KLA | 1.15 |
1.01 |
1.13 |
1.13 |
1.12 |
1.06 |
1.12 |
| ATP | .96 |
1.02 |
1.04 |
1.02 |
.96 |
2.62 |
2.40 |
| KLA/ATP | 1.00 |
1.04 |
1.09 |
1.08 |
1.15 |
1.91 |
2.69 |
|
Blvrb | |
NM_144923 |
biliverdin reductase B (flavin reductase (NADPH)) (Blvrb), mRNA [NM_144923] |
KLA | .92 |
.92 |
.90 |
.97 |
1.03 |
1.08 |
1.45 |
| ATP | 1.08 |
1.10 |
1.14 |
1.22 |
1.28 |
2.18 |
1.75 |
| KLA/ATP | .97 |
.92 |
.94 |
1.10 |
1.24 |
1.96 |
2.58 |
|
Enpp1 | |
ENSMUST00000105520 |
ens|Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E- NPP 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) (Lymphocyte antigen 41) (Ly-41) [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1 |
KLA | .71 |
.79 |
.64 |
.61 |
.55 |
.51 |
.32 |
| ATP | .85 |
.97 |
.85 |
.72 |
.62 |
.45 |
.28 |
| KLA/ATP | .72 |
.73 |
.61 |
.66 |
.60 |
.55 |
.27 |
|
Enpp1 | |
NM_008813 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1), mRNA [NM_008813] |
KLA | .82 |
.83 |
.77 |
.83 |
.65 |
.64 |
.51 |
| ATP | .89 |
.90 |
1.21 |
1.00 |
.98 |
.87 |
.64 |
| KLA/ATP | .72 |
.76 |
.96 |
.87 |
1.00 |
.94 |
.51 |
|
Enpp3 | |
BC005527 |
ectonucleotide pyrophosphatase [BC005527] |
KLA | 1.06 |
.99 |
.98 |
1.01 |
.97 |
.99 |
.96 |
| ATP | .93 |
1.08 |
.99 |
1.05 |
.94 |
1.05 |
1.10 |
| KLA/ATP | .95 |
.96 |
1.10 |
.99 |
.95 |
.94 |
1.03 |
|
Enpp3 | |
BC006944 |
ectonucleotide pyrophosphatase/phosphodiesterase 3, mRNA (cDNA clone IMAGE:2655671), complete cds. [BC006944] |
KLA | 1.02 |
1.01 |
1.03 |
1.08 |
1.04 |
1.01 |
1.01 |
| ATP | .97 |
1.01 |
.96 |
1.00 |
.98 |
1.07 |
.99 |
| KLA/ATP | 1.01 |
.99 |
1.07 |
1.02 |
.97 |
.98 |
.92 |
|
Enpp3 | |
NM_134005 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 (Enpp3), mRNA [NM_134005] |
KLA | 1.01 |
.95 |
.99 |
.98 |
1.05 |
1.04 |
.98 |
| ATP | .98 |
.98 |
1.03 |
.98 |
.96 |
1.00 |
.98 |
| KLA/ATP | .97 |
1.03 |
1.04 |
.93 |
1.02 |
.99 |
1.04 |
|
Flad1 | |
NM_177041 |
RFad1, flavin adenine dinucleotide synthetase, homolog (yeast) (Flad1), mRNA [NM_177041] |
KLA | .86 |
.91 |
.90 |
1.00 |
1.13 |
1.42 |
1.85 |
| ATP | .94 |
.96 |
.95 |
.99 |
.68 |
1.02 |
2.24 |
| KLA/ATP | .84 |
.82 |
.78 |
.87 |
.70 |
1.08 |
2.77 |
|
Mm.23812 7 | |
168823498 |
Unknown |
KLA | 1.07 |
.97 |
1.04 |
1.05 |
1.02 |
.98 |
1.02 |
| ATP | .95 |
1.00 |
.98 |
1.01 |
.95 |
.93 |
.92 |
| KLA/ATP | .93 |
.98 |
.98 |
1.04 |
1.01 |
1.02 |
.98 |
|
Mm.35983 1 | |
159032061 |
Unknown |
KLA | 1.02 |
.93 |
.95 |
.94 |
1.01 |
.97 |
1.11 |
| ATP | .97 |
1.01 |
1.07 |
1.03 |
.93 |
1.03 |
1.02 |
| KLA/ATP | .94 |
.91 |
.99 |
.97 |
.97 |
.98 |
.91 |
|
Rfk | |
NM_019437 |
riboflavin kinase (Rfk), mRNA [NM_019437] |
KLA | 1.03 |
1.05 |
.97 |
.96 |
.86 |
.77 |
.86 |
| ATP | 1.05 |
1.20 |
1.16 |
1.43 |
1.21 |
1.23 |
1.24 |
| KLA/ATP | 1.04 |
1.09 |
.95 |
1.20 |
.91 |
.93 |
1.03 |
|
Tyr | |
NM_011661 |
tyrosinase (Tyr), mRNA [NM_011661] |
KLA | .99 |
1.02 |
.99 |
1.01 |
1.00 |
1.01 |
1.03 |
| ATP | 1.01 |
.98 |
.99 |
1.03 |
1.00 |
1.01 |
1.00 |
| KLA/ATP | 1.01 |
1.00 |
1.00 |
1.01 |
1.00 |
1.03 |
.98 |
|